HEALTH ECONOMICS+POLICY-MINDTAP
HEALTH ECONOMICS+POLICY-MINDTAP
7th Edition
ISBN: 9781337106689
Author: Henderson
Publisher: CENGAGE L
Question
Book Icon
Chapter 4, Problem 1QAP

(a)

To determine

The dominant alternatives from the given treatments and the reason for them being dominant.

(a)

Expert Solution
Check Mark

Explanation of Solution

The dominant treatment option for heart diseases is option F. Although it is the most costly option, it has the highest QALY value as well. Heart disease is something that could be considered will put an individual between life and death. Hence, having to spend more for a longer period of life would be worthwhile. Furthermore, option K could be considered dominant out of various cancer treatments. The cost of the treatment when compared with the QALY value seems reasonable. Due to the nature of the disease, a period of nine years at the respective cost could be considered worthwhile. Option R could be named as dominant under the infectious disease category. As the diseases are infectious spending a higher amount which also has a higher QALY value could be considered prudent.

Economics Concept Introduction

Introduction:

The table shows the costs that must be borne in relation to various types of treatment for three selected diseases. Together with the costs the QALY figures are also given for each treatment option. A QALY or quality adjusted life year is a measure that takes into account the life expectancy in years together with an element of the quality of life, which is often not considered. The QALY measure ranges from zero which is equal to death to one which is considered perfect health.

(b)

To determine

The incremental costs, QALY’s and incremental cost effectiveness ratios for the most prudent treatment options.

(b)

Expert Solution
Check Mark

Explanation of Solution

The incremental cost of option C under heart disease is the most rational choice. The incremental cost effectiveness ratio of it being 25 suggests that a patient would live another 33.3 years. This option seems more realistic as well as economically rational. Under the category of cancer, option H is the most rationale. A patient in this category could live another 25 years at an incremental cost of 200. Option O, the most rational choice under infectious diseases provides a patient with another 50 years to live at an incremental cost of 100.

Economics Concept Introduction

Introduction:

The incremental cost effectiveness ratio is instrumental in providing a systematic means in obtaining certain health standards pertaining to an entire population subject to budgetary constraints. Given that the most effective treatment option is also the least expensive, it would be favorable for policy makers. On the other hand, if the most effective option is also the most expensive, policy makers would be brought into a challenging situation.

(c)

To determine

The graphical representation of various diseases.

(c)

Expert Solution
Check Mark

Explanation of Solution

The graph for heart disease is as follows;

  HEALTH ECONOMICS+POLICY-MINDTAP, Chapter 4, Problem 1QAP , additional homework tip  1

A heart disease being a decisive factor of life of a person is a disease where people opt to spend without hesitation. Hence, treatment option F could be considered a dominant option. Even the cost of it is the highest, so is the QALY value.

The graph for cancer is as follows;

  HEALTH ECONOMICS+POLICY-MINDTAP, Chapter 4, Problem 1QAP , additional homework tip  2

The chance of survival of a cancer patient is considered minimal. Even after receiving the necessary treatment and controlling the spreading of cancer cells, it would still rise even after years. In that note, option K seems prudent, as its cost and the QALY value appears to be realistic.

The graph for infectious diseases is as follows;

  HEALTH ECONOMICS+POLICY-MINDTAP, Chapter 4, Problem 1QAP , additional homework tip  3

As infectious diseases could create great harm to a society, it is prudent that all necessary measures are taken on a timely manner to prevent them from spreading. Hence, option R could be considered dominant.

Economics Concept Introduction

Introduction:

To show the two dimensions of cost per treatment and QALYs gained for the three selected diseases, graphs are being used. The vertical axes of the graphs depict the QALY values for each treatment option under each disease. A QALY or a quality adjusted life year is similar to a measure of life expectancy that comes together with a quality element attached. There are instances in life where even the life expectancy is high; the quality of life is poor. The QALY measure has been developed in addressing this issue.

(d)

To determine

The best treatment strategy from the standpoint of public health.

(d)

Expert Solution
Check Mark

Explanation of Solution

Different professionals as well as patients may carry varying viewpoints on priorities given to various treatment options and illnesses. However, when looked at it from the standpoint of the society at large, it could be said that illnesses that create an impact upon a larger fraction of the society should be given priority. Illnesses such as heart diseases and cancer are undoubtedly wide spread around the globe within the current context. However, they are not contagious diseases and thus the necessary treatment must be obtained at individual level. However, infectious diseases spread much widely at a higher speed. Further, due to their infectiousness, many people would be affected if necessary precautions are not being taken. Hence, option R would be the most prudent strategy. Although the cost of the option is high, amounting to 650, so is the QALY value.

Economics Concept Introduction

Introduction:

Within any society, there are various types of diseases as well as numerous treatment options. The costs involved with such treatments differ. Together with the costs, the quality component of treatments that would be felt by the patients shall also change. Further, it would be much difficult for public health authorities to correctly identify what disease should be given priority as well as what treatment option should be promoted.

Want to see more full solutions like this?

Subscribe now to access step-by-step solutions to millions of textbook problems written by subject matter experts!
Students have asked these similar questions
. The health authorities are considering the treatmentalternatives for three types of diseases: heart disease,cancer, and infectious disease. Each year there are10,000 new cases of heart disease, 10,000 new casesof cancer, and 5,000 new cases of infectious disease.For each diagnosis, there are a number of mutuallyindependent treatment alternatives (including notreatment) as shown in the following table. a. Identify all dominant treatment alternatives.Explain why each is dominant.b. Calculate the incremental cost, incrementalQALYs, and ICERs for all economicallyrational strategies (ICER 5 incremental cost/incremental QALYs). Why are these consideredeconomically rational?c. Using separate graphs for heart disease, cancer,and infectious disease, show the alternativetreatment options, label the dominant options,and show the economically feasible alternatives.(Place QALYs on the vertical axis and cost pertreatment on the horizontal axis.)d. The local health district has asked your opinion…
Assume that people receiving intervention A live 5 years at quality of life of 0.8 and people receiving intervention B live 10 years at quality of life of 0.4. Assume further that the two intervention have equal costs. Compare the cost-effectiveness of these interventions relative to each other and discuss how that would be altered by inclusion of future costs for younger adults and older adults.
One of the key provisions of the Affordable Care Act was the ensuring coverage for “pre- existing conditions,” which had formerly been excluded from insurance plans as people with known medical conditions that will require treatment with certainty, the costs of which are virtually guaranteed to be more than the premiums that insurance companies could charge Suppose we have a population of patients with different health profiles, so that the cost of future treatment X is uniformly distributed on the interval [0, 1000],                    X˜  ∼ U [0, 1000]. Suppose that we have an insurance company that is bound to offer the same plan to all customers who wish to buy it and cannot deny coverage based on pre-existing conditions. The market for insurance is competitive, so that the insurance company must set its premium equal to the expected future payout.                             P  = E[X˜]    Another key provision  of  the  ACA  was  the “individual  mandate,”  which  required…
Knowledge Booster
Background pattern image
Similar questions
SEE MORE QUESTIONS
Recommended textbooks for you
Text book image
EBK HEALTH ECONOMICS AND POLICY
Economics
ISBN:9781337668279
Author:Henderson
Publisher:YUZU